Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2017
At a glance
- Drugs Istradefylline (Primary) ; Rifampicin
- Indications Bacterial infections; Parkinson's disease
- Focus Pharmacokinetics; Registrational
- Sponsors Kyowa Hakko Kirin
- 07 Sep 2017 Results published in the Journal of Clinical Pharmacology
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.